Cover Image
Market Research Report

Analyzing Generics Market in Brazil 2017

Published by Aruvian's R'search Product code 483036
Published Content info 70 pages
Immediate Delivery Available
Price
Back to Top
Analyzing Generics Market in Brazil 2017
Published: March 1, 2017 Content info: 70 pages
Description

Brazil has a booming pharmaceutical market. The pharmaceutical industry in Brazil is the sixth biggest in the world in terms of value. While generics does not have a leading market share in the industry as of yet, it is growing slowly. Prescription drugs account for nearly half of the market, while OTC drugs make up for 27% of the sector. Generics account for 23% as of present.

The generic industry in Brazil has been experiencing some decline in recent years, though it has managed to increase its market share. The market has seen fierce competition within domestic players and this has affected the overall value growth of the industry.

Aruvian Research presents Analyzing Generics Market in Brazil 2017 - a comprehensive coverage of the Brazilian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.

The Generics Industry in Brazil is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.

We also include a Porter's Five Forces analysis of the Brazilian Generics Industry.

Analysis of the major industry players in the Brazilian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include O Aché Laboratórios Farmacêuticos SA, Sanofi, Eurofarma Laboratórios Ltda and others. This concludes this comprehensive research report from Aruvian Research.

Table of Contents

Table of Contents

A. Executive Summary

B. Analyzing the Global Generics Industry

  • B.1 Industry Definition
  • B.2 Industry Overview
  • B.3 Industry Value & Volume Analysis
  • B.4 Industry Segmentation by Geography
  • B.5 Patent Expiries
  • B.6 Global Generic Industry Structure
  • B.7 Industry Forecast

C. Generics Industry in Brazil

  • C.1 Industry Overview
  • C.2 Industry Value & Volume
  • C.3 Industry Segmentation by Geography
  • C.4 Industry Forecast

D. Generics Industry in Brazil: Porter's Five Forces Strategy Analysis

  • D.1 Introduction
  • D.2 Bargaining Power of Buyers
  • D.3 Bargaining Power of Suppliers
  • D.4 Competitive Rivalry in the Industry
  • D.5 Threat of New Entrants
  • D.6 Threat of Substitutes

E. Major Industry Players

  • E.1 Allergan Plc
    • E.1.1 Corporate Analysis
    • E.1.2 Financial Analysis
    • E.1.3 SWOT Analysis
  • E.2 Les Laboratoires Servier
    • E.2.1 Corporate Analysis
    • E.2.2 Financial Analysis
    • E.2.3 SWOT Analysis
  • E.3 Sanofi SA
    • E.3.1 Corporate Analysis
    • E.3.2 Financial Analysis
    • E.3.3 SWOT Analysis
  • E.4 EMS Sigma Pharma
  • E.5 Eurofarma Laboratórios Ltda
  • E.6 O Aché Laboratórios Farmacêuticos SA

F. Glossary of Terms

List of Figures

  • Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
  • Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
  • Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
  • Figure 4: Global Generics Market Segmentation by Geography (%), 2016
  • Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
  • Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
  • Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
  • Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
  • Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
  • Figure 10: Value of the Generics Market in Brazil (in USD Billion), 2012-2016
  • Figure 11: Volume Growth of the Generics Market in Brazil (%), 2012-2016
  • Figure 12: Share of Brazil in the Americas Generics Industry (%), 2016
  • Figure 13: Forecast of the Generics Market in Brazil (in USD Billion), 2016-2021
  • Figure 14: Volume Forecast of the Generics Market in Brazil (%), 2016-2021
  • Figure 15: Porter's Five Forces Strategy Analysis of the Generics Industry in Brazil
  • Figure 16: Bargaining Power of Buyers in the Brazilian Generics Industry
  • Figure 17: Bargaining Power of Suppliers in the Brazilian Generics Industry
  • Figure 18: Competitive Rivalry in the Brazilian Generics Industry
  • Figure 19: Threat of New Entrants to the Brazilian Generics Industry
  • Figure 20: Threat of Substitutes to the Brazilian Generics Industry
  • Figure 21: Revenues & Profitability of Allergan Plc (in USD Million), 2011-2015
  • Figure 22: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015

List of Tables

  • Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
  • Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
  • Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
  • Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
  • Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
  • Table 6: Value of the Generics Market in Brazil (in USD Billion), 2012-2016
  • Table 7: Volume Growth of the Generics Market in Brazil (%), 2012-2016
  • Table 8: Share of Brazil in the Americas Generics Industry (in USD Billion & %), 2016
  • Table 9: Forecast of the Generics Market in Brazil (in USD Billion), 2016-2021
  • Table 10: Volume Forecast of the Generics Market in Brazil (%), 2016-2021
  • Table 11: Key Financials of Allergan Plc (in USD Million), 2011-2015
  • Table 12: Key Financials of Sanofi SA (in USD Million), 2011-2015
Back to Top